Toll-like receptor 4: Innate immune regulator of neuroimmune and neuroendocrine interactions in stress and major depressive disorder

Frontiers in Neuroscience

Volumn 8, Issue SEP, 2014, Pages

  Liu, JiaJun ^a   Buisman Pijlman, Femke ^a   Hutchinson, Mark Rowland ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Depression; HPA; MDD; Neuroendocrine; Neuroimmunology; Stress; TLR4; Toll like receptor 4

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYCLOOXYGENASE 2; CYTOKINE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 72; HIGH MOBILITY GROUP B1 PROTEIN; INDOLEAMINE 2,3 DIOXYGENASE; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MELANOCORTIN 2 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

ADAPTATION; ANHEDONIA; ANOREXIA; ASTROCYTE; BEHAVIOR; BEHAVIOR CHANGE; BLOOD BRAIN BARRIER; CYTOKINE RESPONSE; DEPRESSION; DRUG TARGETING; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOMODULATION; INNATE IMMUNITY; INTESTINE FLORA; INTRACELLULAR SIGNALING; LETHARGY; LOCOMOTION; MAJOR DEPRESSION; MICROGLIA; MOOD DISORDER; NERVOUS SYSTEM INFLAMMATION; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PATHOPHYSIOLOGY; SEROTONINERGIC TRANSMISSION; STEROIDOGENESIS; STRESS;

EID: 84908670733     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00309     Document Type: Article

References (168)

1. Acharjee , S., Nayani, N., Tsutsui, M., Hill, M., Ousman, S, and Pittman, Q. (2013). Altered cognitive-emotional behavior in early experimental autoimmune encephalitis - Cytokine and hormonal correlates. Brain, Behaviour, and Immunity 33. doi: 10.1016/j.bbi.2013.07.003.
2. Agresti, A., Scaffidi, P., Riva, A., Caiolfa, V., and Bianchi, M. (2005). GR and HMGB1 Interact Only within Chromatin and Influence Each Other's Residence Time. Molecular Cell 18. doi:10.1016/j.molcel.2005.03.005.
3. Aguirre, A., Maturana, C., Harcha, P., and Sáez, J. (2013). Possible involvement of TLRs and hemichannels in stress-induced CNS dysfunction via mastocytes, and glia activation. Mediators of inflammation 2013, 893521. doi:10.1155/2013/893521.
4. Ajmone-Cat, M., Mancini, M., Simone, R., Cilli, P., and Minghetti, L. (2013). Microglial polarization and plasticity: evidence from organotypic hippocampal slice cultures. Glia 61, 1698-711. doi:10.1002/glia.22550.
5. Akira, S., and Takeda, K. (2004). Toll-like receptor signalling. Nature Reviews Immunology 4, 499- 511. doi:10.1038/nri1391.
6. Alboni, S., Benatti, C., Montanari, C., Tascedda, F., and Brunello, N. (2013). Chronic antidepressant treatments resulted in altered expression of genes involved in inflammation in the rat hypothalamus. European Journal of Pharmacology 721, 158167. doi:10.1016/j.ejphar.2013.08.046.
7. Alexander, J., Cox, G., Tian, J.-B., Zha, A., Wei, P., Kigerl, K., Reddy, M., Dagia, N., Sielecki, T., Zhu, M., et al. (2012). Macrophage migration inhibitory factor (MIF) is essential for inflammatory and neuropathic pain and enhances pain in response to stress. Experimental neurology 236, 351-62. doi:10.1016/j.expneurol.2012.04.018.
8. Alysandratos, K.-D., Asadi, S., Angelidou, A., Zhang, B., Sismanopoulos, N., Yang, H., Critchfield, A., and Theoharides, T. (2012). Neurotensin and CRH interactions augment human mast cell activation. PloS one 7, e48934. doi:10.1371/journal.pone.0048934.
9. American Pschiatric Association (2013). "Depressive disorders" in Diagnostic and statistical manual of mental disorders 5th ed. Arlington, VA: American Psychiatric Publishing. DOI: 10.1176/appi.books.9780890425596.807874.
10. Anisman, H., and Hayley, S. (2012). Inflammatory factors contribute to depression and its comorbid conditions. Science signaling 5, pe45. doi:10.1126/scisignal.2003579.
11. Araque, A., Carmignoto, G., Haydon, P., Oliet, S., Robitaille, R., and Volterra, A. (2014). Gliotransmitters travel in time and space. Neuron 81, 728-39. doi:10.1016/j.neuron.2014.02.007.
12. Arroll, B., Elley, C. R., Fishman, T., Goodyear-Smith, F. A., Kenealy, T., Blashki, G., Kerse, N., and Macgillivray, S. (2009). Antidepressants versus placebo for depression in primary care. The Cochrane database of systematic reviews, CD007954. doi:10.1002/14651858.CD007954.
13. Audet, M.-C., Jacobson-Pick, S., Wann, B., and Anisman, H. (2011). Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges. Brain, behavior, and immunity 25, 1197-205. doi:10.1016/j.bbi.2011.03.010.
14. Banati, R. B. (2003). Neuropathological imaging: in vivo detection of glial activation as a measure of disease and adaptive change in the brain. British medical bulletin 65, 121-31.
15. Ait-Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Houdeau, E., Theodorou, V., and Tompkins, T. (2014). Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society 26, 510-20. doi:10.1111/nmo.12295.
16. Ait-Belgnaoui, A., Durand, H., Cartier, C., Chaumaz, G., Eutamene, H., Ferrier, L., Houdeau, E., Fioramonti, J., Bueno, L., and Theodorou, V. (2012). Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 37, 1885-95. doi:10.1016/j.psyneuen.2012.03.024.
17. Beschorner, R., Simon, P., Schauer, N., Mittelbronn, M., Schluesener, H., Trautmann, K., Dietz, K., and Meyermann, R. (2007). Reactive astrocytes and activated microglial cells express EAAT1, but not EAAT2, reflecting a neuroprotective potential following ischaemia. Histopathology 50, 897-910. doi:10.1111/j.1365-2559.2007.02703.x.
18. Bilbo, S., and Schwarz, J. (2009). Early-life programming of later-life brain and behavior: a critical role for the immune system. Frontiers in behavioral neuroscience 3, 14. doi:10.3389/neuro.08.014.2009.
19. Billing, A., Revets, D., Hoffmann, C., Turner, J., Vernocchi, S., and Muller, C. (2012). Proteomic profiling of rapid non-genomic and concomitant genomic effects of acute restraint stress on rat thymocytes. Journal of proteomics 75, 2064-79. doi:10.1016/j.jprot.2012.01.008.
20. Bogaert, T., Bosscher, K., and Libert, C. (2010). Crosstalk between TNF and glucocorticoid receptor signaling pathways. Cytokine & growth factor reviews 21, 275-86. doi:10.1016/j.cytogfr.2010.04.003.
21. Brevet, M., Kojima, H., Asakawa, A., Atsuchi, K., Ushikai, M., Ataka, K., Inui, A., Kimura, H., Sevestre, H., and Fujimiya, M. (2010). Chronic foot-shock stress potentiates the influx of bone marrow-derived microglia into hippocampus. Journal of neuroscience research 88, 1890-7. doi:10.1002/jnr.22362.
22. Burke, N., Kerr, D., Moriarty, O., Finn, D., and Roche, M. (2014). Minocycline modulates neuropathic pain behaviour and cortical M1-M2 microglial gene expression in a rat model of depression. Brain, Behavior, and Immunity. doi:10.1016/j.bbi.2014.06.015.
23. Calandra, T., Bernhagen, J., Metz, C., Spiegel, L., Bacher, M., Donnelly, T., Cerami, A., and Bucala, R. (1995). MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377, 68-71. doi:10.1038/377068a0.
24. Carvalho, L., Bergink, V., Sumaski, L., Wijkhuijs, J., Hoogendijk, W., Birkenhager, T., and Drexhage, H. (2014). Inflammatory activation is associated with a reduced glucocorticoid receptor alpha/beta expression ratio in monocytes of inpatients with melancholic major depressive disorder. Translational Psychiatry 4, e344. doi:10.1038/tp.2013.118.
25. Chen, S., Ma, Q., Krafft, P., Hu, Q., Rolland, W., Sherchan, P., Zhang, J., Tang, J., and Zhang, J. (2013). P2X7R/cryopyrin inflammasome axis inhibition reduces neuroinflammation after SAH. Neurobiology of disease 58, 296-307. doi:10.1016/j.nbd.2013.06.011.
26. Chover-Gonzalez, A. J., Harbuz, M. S., and Lightman, S. L. (1993). Effect of adrenalectomy and stress on interleukin-1 beta-mediated activation of hypothalamic corticotropin-releasing factor mRNA. Journal of neuroimmunology 42, 155-60.
27. Chrousos, G. (2009). Stress and disorders of the stress system. Nature reviews. Endocrinology 5, 374-81. doi:10.1038/nrendo.2009.106.
28. Chung, Y., Kim, S., Park, J.-Y., Chung, E., Park, K., Won, S., Bok, E., Jin, M., Park, E., Yoon, S.-H., et al. (2011). Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology 60, 963-74. doi:10.1016/j.neuropharm.2011.01.043.
29. Colaco, C., Bailey, C., Walker, K., and Keeble, J. (2013). Heat shock proteins: stimulators of innate and acquired immunity. BioMed research international 2013, 461230. doi:10.1155/2013/461230.
30. Corona, A. W., Huang, Y., O'Connor, J. C., Dantzer, R., Kelley, K. W., Popovich, P. G., and Godbout, J. P. (2010). Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. Journal of neuroinflammation 7, 93. doi:10.1186/1742-2094-7-93.
31. D'Mello, C., Riazi, K., Le, T., Stevens, K., Wang, A., McKay, D., Pittman, Q., and Swain, M. (2013). P-Selectin-Mediated Monocyte-Cerebral Endothelium Adhesive Interactions Link Peripheral Organ Inflammation To Sickness Behaviors. The Journal of Neuroscience 33, 14878-14888. doi:10.1523/JNEUROSCI.1329-13.2013.
32. Dantzer, R. (2004). Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. European Journal of Pharmacology 500, 399411. doi:10.1016/j.ejphar.2004.07.040.
33. Dantzer, R., and Kelley, K. (2007). Twenty years of research on cytokine-induced sickness behavior. Brain, Behavior, and Immunity 21, 153160. doi:10.1016/j.bbi.2006.09.006.
34. Dawson, C., Dhanda, A., Conway-Campbell, B., Dimambro, A., Lightman, S., and Dayan, C. (2012). NF?B and glucocorticoid receptor activity in steroid resistance. Journal of receptor and signal transduction research 32, 29-35. doi:10.3109/10799893.2011.641977.
35. Deak, T., Bordner, K., McElderry, N., Barnum, C., Blandino, P., Deak, M., and Tammariello, S. (2005). Stress-induced increases in hypothalamic IL-1: a systematic analysis of multiple stressor paradigms. Brain Research Bulletin 64, 541556. doi:10.1016/j.brainresbull.2004.11.003.
36. Dey, A., Hao, S., Erion, J., Wosiski-Kuhn, M., and Stranahan, A. (2014). Glucocorticoid sensitization of microglia in a genetic mouse model of obesity and diabetes. Journal of neuroimmunology 269, 20-7. doi:10.1016/j.jneuroim.2014.01.013.
37. Dhami, K., Churchward, M., Baker, G., and Todd, K. (2013). Fluoxetine and citalopram decrease microglial release of glutamate and d-serine to promote cortical neuronal viability following ischemic insult. Molecular and Cellular Neuroscience 56, 365374. doi:10.1016/j.mcn.2013.07.006.
38. Dinan, T. (1994). Glucocorticoids and the genesis of depressive illness. A psychobiological model. The British Journal of Psychiatry 164, 365371. doi:10.1192/bjp.164.3.365.
39. Dobos, N., Vries, E., Kema, I., Patas, K., Prins, M., Nijholt, I., Dierckx, R., Korf, J., Boer, J., Luiten, P., et al. (2012). The role of indoleamine 2,3-dioxygenase in a mouse model of neuroinflammation-induced depression. Journal of Alzheimer's disease: JAD 28, 905-15. doi:10.3233/jad-2011-111097.
40. Domenici, E., Willé, D., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C., et al. (2010). Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PloS one 5, e9166. doi:10.1371/journal.pone.0009166.
41. Du, Q., Min, S., Chen, L.-Y. Y., Ma, Y.-D. D., Guo, X.-L. L., Wang, Z., and Wang, Z.-G. G. (2012). Major stress hormones suppress the response of macrophages through down-regulation of TLR2 and TLR4. The Journal of surgical research 173, 354-61. doi:10.1016/j.jss.2010.10.016.
42. Elenkov, I. J., Kovács, K., Kiss, J., Bertók, L., and Vizi, E. S. (1992). Lipopolysaccharide is able to bypass corticotrophin-releasing factor in affecting plasma ACTH and corticosterone levels: evidence from rats with lesions of the paraventricular nucleus. The Journal of endocrinology 133, 231-6.
43. Fang, J., Han, D., Hong, J., Tan, Q., and Tian, Y. (2012). The chemokine, macrophage inflammatory protein-2y, reduces the expression of glutamate transporter-1 on astrocytes and increases neuronal sensitivity to glutamate excitotoxicity. Journal of neuroinflammation 9, 267. doi: 10.1186/1742-2094-9-267.
44. Faraco, G., Fossati, S., Bianchi, M., Patrone, M., Pedrazzi, M., Sparatore, B., Moroni, F., and Chiarugi, A. (2007). High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. Journal of Neurochemistry 103, 590603. doi: 10.1111/j.1471-4159.2007.04788.x.
45. Faridhosseini, F., Sadeghi, R., Farid, L., and Pourgholami, M. (2014). Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials. Human Psychopharmacology: Clinical and Experimental 29, 216223. doi:10.1002/hup.2401.
46. Frank, M. G., Miguel, Z. D., Watkins, L. R., and Maier, S. F. (2010). Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide. Brain, behavior, and immunity 24, 19-30. doi:10.1016/j.bbi.2009.07.008.
47. Frank, M. G., Thompson, B. M., Watkins, L. R., and Maier, S. F. (2012). Glucocorticoids mediate stress-induced priming of microglial pro-inflammatory responses. Brain, behavior, and immunity 26, 337-45. doi:10.1016/j.bbi.2011.10.005.
48. Frank, M. G., Watkins, L. R., and Maier, S. F. (2011). Stress- and glucocorticoid-induced priming of neuroinflammatory responses: potential mechanisms of stress-induced vulnerability to drugs of abuse. Brain, behavior, and immunity 25 Suppl 1, S21-8. doi:10.1016/j.bbi.2011.01.005.
49. Frank, M. G., Watkins, L. R., and Maier, S. F. (2013). Stress-induced glucocorticoids as a neuroendocrine alarm signal of danger. Brain, behavior, and immunity 33, 1-6. doi:10.1016/j.bbi.2013.02.004.
50. Frodl, T., Meisenzahl, E. M., Zetzsche, T., Höhne, T., Banac, S., Schorr, C, Jäger, M., Leinsinger, G., Bottlender, R., Reiser, M., et al. (2004). Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. The Journal of clinical psychiatry 65, 492-9.
51. Gadek-Michalska, A., Tadeusz, J., Rachwalska, P., Spyrka, J., and Bugajski, J. (2011). Effect of prior stress on interleukin-1p and HPA axis responses to acute stress. Pharmacological reports: PR 63, 1393-403. doi:10.1016/S1734-1140(11)70703-4.
52. Gadermann, A., Alonso, J., Vilagut, G., Zaslavsky, A., and Kessler, R. (2012). Comorbidity and disease burden in the National Comorbidity Survey Replication (NCS-R). Depression and anxiety 29, 797-806. doi:10.1002/da.21924.
53. Gárate, I., García-Bueno, B., Madrigal, J., Bravo, L., Berrocoso, E., Caso, J., Micó, J., and Leza, J. (2011). Origin and consequences of brain Toll-like receptor 4 pathway stimulation in an experimental model of depression. Journal of neuroinflammation 8, 151. doi: 10.1186/1742- 2094-8-151.
54. Gazal, M., Souza, L., Fucolo, B., Wiener, C, Silva, R., Pinheiro, R., Jansen, K., Ghislene, G., Oses, J., and Kaster, M. (2013). The impact of cognitive behavioral therapy on IL-6 levels in unmedicated women experiencing the first episode of depression: a pilot study. Psychiatry research 209, 742-5. doi:10.1016/j.psychres.2013.03.002.
55. Ghonime, M., Shamaa, O., Das, S., Eldomany, R., Fernandes-Alnemri, T., Alnemri, E., Gavrilin, M., and Wewers, M. (2014). Inflammasome priming by lipopolysaccharide is dependent upon ERK signaling and proteasome function. Journal of immunology (Baltimore, Md.: 1950) 192, 3881-8. doi:10.4049/jimmunol.1301974.
56. Gibb, J., Al-Yawer, F., and Anisman, H. (2013). Synergistic and antagonistic actions of acute or chronic social stressors and an endotoxin challenge vary over time following the challenge. Brain, Behavior, and Immunity 28, 149158. doi:10.1016/j.bbi.2012.11.004.
57. Gimsa, U., Mitchison, N., and Brunner-Weinzierl, M. (2013). Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation. Mediators of Inflammation 2013, 111. doi:10.1155/2013/320519.
58. Goebel, M., Stengel, A., Wang, L., Reeve, J., and Taché, Y. (2011). Lipopolysaccharide increases plasma levels of corticotropin-releasing hormone in rats. Neuroendocrinology 93, 165-73. doi:10.1159/000322590.
59. Gong, J., Zhu, B., Murshid, A., Adachi, H., Song, B., Lee, A., Liu, C., and Calderwood, S. (2009). T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1. Journal of immunology (Baltimore, Md.: 1950) 183, 3092-8. doi:10.4049/jimmunol.0901235.
60. Gregory, J. L., Hall, P., Leech, M., Morand, E. F., and Hickey, M. J. (2009). Independent roles of macrophage migration inhibitory factor and endogenous, but not exogenous glucocorticoids in regulating leukocyte trafficking. Microcirculation (New York, N.Y.: 1994) 16, 735-48. doi:10.3109/10739680903210421.
61. Grieb, G., Simons, D., Eckert, L., Hemmrich, M., Steffens, G., Bernhagen, J., and Pallua, N. (2012). Levels of macrophage migration inhibitory factor and glucocorticoids in chronic wound patients and their potential interactions with impaired wound endothelial progenitor cell migration. Wound repair and regeneration: official publication of the Wound Healing Society [and] the European Tissue Repair Society 20, 707-14. doi:10.1111/j.1524- 475x.2012.00817.x.
62. Guan, X., Shao, F., Xie, X., Chen, L., and Wang, W. (2014). Effects of aspirin on immobile behavior and endocrine and immune changes in the forced swimming test: Comparison to fluoxetine and imipramine. Pharmacology Biochemistry and Behavior 124, 361366. doi:10.1016/j.pbb.2014.07.002.
63. Halassa, M., Fellin, T., Takano, H., Dong, J.-H., and Haydon, P. (2007). Synaptic Islands Defined by the Territory of a Single Astrocyte. The Journal of Neuroscience 27, 6473-6477. doi:10.1523/JNEUROSCI.1419-07.2007.
64. Harms, A., Cao, S., Rowse, A., Thome, A., Li, X., Mangieri, L., Cron, R., Shacka, J., Raman, C., and Standaert, D. (2013). MHCII is required for a-synuclein-induced activation of microglia, CD4 T cell proliferation, and dopaminergic neurodegeneration. The Journal of neuroscience: the official journal of the Society for Neuroscience 33, 9592-600. doi:10.1523/jneurosci.5610- 12.2013.
65. Heneka, M., Kummer, M., and Latz, E. (2014). Innate immune activation in neurodegenerative disease. Nature Reviews Immunology 14, 463477. doi:10.1038/nri3705.
66. Hines, D., Choi, H., Hines, R., Phillips, A., and MacVicar, B. (2013). Prevention of LPS-induced microglia activation, cytokine production and sickness behavior with TLR4 receptor interfering peptides. PloS one 8, e60388. doi:10.1371/journal.pone.0060388.
67. Holsboer-Trachsler, E., Stohler, R., and Hatzinger, M. (1991). Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression. Psychiatry research 38, 163-71.
68. Horikawa, H., Kato, T., Mizoguchi, Y., Monji, A., Seki, Y., Ohkuri, T., Gotoh, L., Yonaha, M., Ueda, T., Hashioka, S., et al. (2010). Inhibitory effects of SSRIs on IFN-? induced microglial activation through the regulation of intracellular calcium. Progress in Neuro- Psychopharmacology and Biological Psychiatry 34, 13061316. doi:10.1016/j.pnpbp.2010.07.015.
69. Hsiao, E., McBride, S., Hsien, S., Sharon, G., Hyde, E., McCue, T., Codelli, J., Chow, J., Reisman, S., Petrosino, J., et al. (2013). Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155, 1451-63. doi:10.1016/j.cell.2013.11.024.
70. Huang, Y., Henry, C., Dantzer, R., Johnson, R., and Godbout, J. (2008). Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiology of Aging 29, 17441753. doi:10.1016/j.neurobiolaging.2007.04.012.
71. Hueston, C., and Deak, T. (2014). The inflamed axis: The interaction between stress, hormones, and the expression of inflammatory-related genes within key structures comprising the hypothalamic-pituitary-adrenal axis. Physiology & Behavior 124, 7791. doi:10.1016/j.physbeh.2013.10.035.
72. Hutchinson, M., Ramos, K., Loram, L., Wieseler, J., Sholar, P., Kearney, J., Lewis, M., Crysdale, N., Zhang, Y., Harrison, J., et al. (2009). Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats. Neuroscience 164, 1821-32. doi:10.1016/j.neuroscience.2009.09.046.
73. Hutchinson, M., and Watkins, L. (2014). Why is neuroimmunopharmacology crucial for the future of addiction research? Neuropharmacology 76 Pt B, 218-27. doi:10.1016/j.neuropharm.2013.05.039.
74. Jacobsen, J., Watkins, L., and Hutchinson, M. (2014). Discovery of a Novel Site of Opioid Action at the Innate Immune Pattern-Recognition Receptor TLR4 and its Role in Addiction.International review of neurobiology 118, 129-63. doi:10.1016/b978-0-12-801284- 0.00006-3.
75. Jarcho, M., Slavich, G., Tylova-Stein, H., Wolkowitz, O., and Burke, H. (2013). Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder. Biological psychology 93, 150-8. doi:10.1016/j.biopsycho.2013.01.018.
76. Kanczkowski, W., Alexaki, V.-I., Tran, N., Grobklaus, S., Zacharowski, K., Martinez, A., Popovics, P., Block, N., Chavakis, T., Schally, A., et al. (2013). Hypothalamo-pituitary and immunedependent adrenal regulation during systemic inflammation. Proceedings of the National Academy of Sciences of the United States of America 110, 14801-6. doi:10.1073/pnas.1313945110.
77. Kelley, K., and McCusker, R. (2014). Getting nervous about immunity. Seminars in Immunology. doi:10.1016/j.smim.2014.01.011.
78. Kéri, S., Szabó, C., and Kelemen, O. (2014). Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder. Brain, Behavior, and Immunity. doi:10.1016/j.bbi.2014.03.020.
79. Kim, S., Kim, S., Pribis, J., Lotze, M., Mollen, K., Shapiro, R., Loughran, P., Scott, M., and Billiar, T. (2013). Signaling of high mobility group box 1 (HMGB1) through toll-like receptor 4 in macrophages requires CD14. Molecular Medicine 19, 1. doi:10.2119/molmed.2012.00306.
80. Kreisel, T., Frank, M., Licht, T., Reshef, R., Ben-Menachem-Zidon, O., Baratta, M., Maier, S., and Yirmiya, R. (2014). Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis. Molecular psychiatry 19, 699-709. doi:10.1038/mp.2013.155.
81. Kumari, B., Kumar, A., and Dhir, A. (2007). Protective effect of non-selective and selective COX-2- inhibitors in acute immobilization stress-induced behavioral and biochemical alterations. Pharmacological reports: PR 59, 699-707.
82. Laird, M., Shields, J., Sukumari-Ramesh, S., Kimbler, D., Fessler, R., Shakir, B., Youssef, P., Yanasak, N., Vender, J., and Dhandapani, K. (2014). High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of toll-like receptor 4. Glia 62, 2638. doi:10.1002/glia.22581.
83. Lerch, J., Puga, D., Bloom, O., and Popovich, P. (2014). Glucocorticoids and macrophage migration inhibitory factor (MIF) are neuroendocrine modulators of inflammation and neuropathic pain after spinal cord injury. Seminars in Immunology. doi:10.1016/j.smim.2014.03.004.
84. Lewis, S. S., Loram, L. C., Hutchinson, M. R., Li, C.-M. M., Zhang, Y., Maier, S. F., Huang, Y., Rice, K. C., and Watkins, L. R. (2012). (+)-naloxone, an opioid-inactive toll-like receptor 4 signaling inhibitor, reverses multiple models of chronic neuropathic pain in rats. The journal of pain: official journal of the American Pain Society 13, 498-506. doi:10.1016/j.jpain.2012.02.005.
85. Lichtblau, N., Schmidt, F., Schumann, R., Kirkby, K., and Himmerich, H. (2013). Cytokines as biomarkers in depressive disorder: current standing and prospects. International review of psychiatry (Abingdon, England) 25, 592-603. doi:10.3109/09540261.2013.813442.
86. Lively, S., and Schlichter, L. (2013). The microglial activation state regulates migration and roles of matrix-dissolving enzymes for invasion. Journal of neuroinflammation 10, 75. doi:10.1186/1742-2094-10-75.
87. Loram, L. C., Taylor, F. R., Strand, K. A., Frank, M. G., Sholar, P., Harrison, J. A., Maier, S. F., and Watkins, L. R. (2011). Prior exposure to glucocorticoids potentiates lipopolysaccharide induced mechanical allodynia and spinal neuroinflammation. Brain, behavior, and immunity 25, 1408-15. doi:10.1016/j.bbi.2011.04.013.
88. Loum-Ribot, E., Lafon, P., Chaigniau, M., Tramu, G., and Corio, M. (2006). Glucocorticoids Down- Regulate Lipopolysaccharide-Induced de novo Production of Neurotensin mRNA in the Rat Hypothalamic, Paraventricular, Corticotrophin-Releasing Hormone Neurons. Neuroimmunomodulation 13, 170-178. doi: 10.1159/000098130.
89. Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundbäck, P., Valdes-Ferrer, S., Olofsson, P., Kalb, T., Roth, J., et al. (2012). Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670-4. doi:10.1038/nature11290.
90. Ma, Y., Matsuwaki, T., Yamanouchi, K., and Nishihara, M. (2013). Cyclooxygenase-2-related signaling in the hypothalamus plays differential roles in response to various acute stresses. Brain research 1508, 23-33. doi:10.1016/j.brainres.2013.02.042.
91. Maes, M., Bosmans, E., Suy, E., Vandervorst, C, DeJonckheere, C, and Raus, J. (1991). Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1? and soluble interleukin-2 receptor production. Acta Psychiatrica Scandinavica 84, 379386. doi: 10.1111/j.1600-0447.1991.tb03163.x.
92. Maes, M., Meltzer, H., Stevens, W., Cosyns, P., and Blockx, P. (1994). Multiple reciprocal relationships between in vivo cellular immunity and hypothalamic-pituitary-adrenal axis in depression. Psychological medicine 24, 167-77. doi:10.1017/S0033291700026933.
93. Malynn, S., Campos-Torres, A., Moynagh, P., and Haase, J. (2013). The pro-inflammatory cytokine TNF-a regulates the activity and expression of the serotonin transporter (SERT) in astrocytes. Neurochemical research 38, 694-704. doi:10.1007/s11064-012-0967-y.
94. Manikowska, K., Mikolajczyk, M., Mikolajczak, P., and Bobkiewicz-Kozlowska, T. (2014). The influence of mianserin on TNF-a, IL-6 and IL-10 serum levels in rats under chronic mild stress. Pharmacological Reports 66, 2227. doi:10.1016/j.pharep.2013.06.003.
95. Martinez Calejman, C, Astort, F., Di Gruccio, J. M., Repetto, E. M., Mercau, M., Giordanino, E., Sanchez, R., Pignataro, O., Arias, P., and Cymeryng, C. B. (2011). Lipopolysaccharide stimulates adrenal steroidogenesis in rodent cells by a NFicB-dependent mechanism involving COX-2 activation. Molecular and cellular endocrinology 337, 1-6. doi: 10.1016/j.mce.2010.12.036.
96. Maslanik, T., Mahaffey, L., Tannura, K., Beninson, L., Greenwood, B., and Fleshner, M. (2013). The inflammasome and danger associated molecular patterns (DAMPs) are implicated in cytokine and chemokine responses following stressor exposure. Brain, behavior, and immunity 28, 54- 62. doi: 10.1016/j.bbi.2012.10.014.
97. Matysiak, M., Makosa, B., Walczak, A., and Selmaj, K. (2008). Patients with multiple sclerosis resisted to glucocorticoid therapy: abnormal expression of heat-shock protein 90 in glucocorticoid receptor complex. Multiple Sclerosis 14, 919926. doi: 10.1177/1352458508090666.
98. McCusker, R., and Kelley, K. (2013). Immune-neural connections: how the immune system's response to infectious agents influences behavior. The Journal of experimental biology 216, 84-98. doi: 10.1242/jeb.073411.
99. Mehet, D., Philip, J., Solito, E., Buckingham, J., and John, C. (2012). Evidence from in vitro and in vivo studies showing that nuclear factor-KB within the pituitary folliculostellate cells and corticotrophs regulates adrenocorticotrophic hormone secretion in experimental endotoxaemia. Journal of neuroendocrinology 24, 862-73. doi: 10.1111/j.1365- 2826.2012.02285.x.
100. Mohn, C, Fernandez-Solari, J., Laurentiis, A., Bornstein, S., Ehrhart-Bornstein, M., and Rettori, V. (2011). Adrenal gland responses to lipopolysaccharide after stress and ethanol administration in male rats. Stress (Amsterdam, Netherlands) 14, 216-26. doi:10.3109/10253890.2010.532254.
101. Monroe, S. M., and Simons, A. D. (1991). Diathesis-stress theories in the context of life stress research: implications for the depressive disorders. Psychological bulletin 110, 406-25.
102. Mouihate, A., Galic, M. A., Ellis, S. L., Spencer, S. J., Tsutsui, S., and Pittman, Q. J. (2010). Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways. The Journal of neuroscience: the official journal of the Society for Neuroscience 30, 7975-83. doi:10.1523/JNEUROSCI.6078-09.2010.
103. Muzikar, K. A., Nickols, N. G., and Dervan, P. B. (2009). Repression of DNA-binding dependent glucocorticoid receptor-mediated gene expression. Proceedings of the National Academy of Sciences of the United States of America 106, 16598-603. doi:10.1073/pnas.0909192106.
104. Na, K.-S., Lee, K., Lee, J., Cho, Y., and Jung, H.-Y. (2014). Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: a meta-analysis. Progress in neuropsychopharmacology & biological psychiatry 48, 79-85. doi:10.1016/j.pnpbp.2013.09.006.
105. Nathanson, N. (2012). Regulation of neurokine receptor signaling and trafficking. Neurochemistry International 61, 874878. doi:10.1016/j.neuint.2012.01.018.
106. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo. Science 308, 1314-1318. doi:10.1126/science.1110647.
107. Novac, N., Baus, D., Dostert, A., and Heinzel, T. (2006). Competition between glucocorticoid receptor and NF?B for control of the human FasL promoter. The FASEB Journal 20, 1074- 1081. doi:10.1096/fj.05-5457com.
108. O'Connor, J., Lawson, M., André, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K., and Dantzer, R. (2009). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Molecular psychiatry 14, 511-22. doi:10.1038/sj.mp.4002148.
109. Obuchowicz, E., Bielecka, A., Paul-Samojedny, M., Pudelko, A., and Kowalski, J. (2014). Imipramine and fluoxetine inhibit LPS-induced activation and affect morphology of microglial cells in the rat glial culture. Pharmacological Reports 66, 3443. doi:10.1016/j.pharep.2013.08.002.
110. Ock, J., Lee, H., Kim, S., Lee, W.-H., Choi, D.-K., Park, E., Kim, S.-H., Kim, I., and Suk, K. (2006). Induction of microglial apoptosis by corticotropin-releasing hormone. Journal of Neurochemistry 98, 962972. doi:10.1111/j.1471-4159.2006.03933.x.
111. Olah, M., Biber, K., Vinet, J., and Boddeke, H. (2011). Microglia Phenotype Diversity. CNS & Neurological Disorders - Drug Targets 10, 108118. doi:10.2174/187152711794488575.
112. Otsuki, K., Uchida, S., Wakabayashi, Y., Matsubara, T., Hobara, T., Funato, H., and Watanabe, Y. (2010). Aberrant REST-mediated transcriptional regulation in major depressive disorder. Journal of psychiatric research 44, 378-84. doi:10.1016/j.jpsychires.2009.09.009.
113. Pace, T., and Miller, A. (2009). Cytokines and glucocorticoid receptor signaling. Relevance to major depression. Annals of the New York Academy of Sciences 1179, 86-105. doi:10.1111/j.1749- 6632.2009.04984.x.
114. Pace, T. W. W., Hu, F., and Miller, A. H. (2007). Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain, behavior, and immunity 21, 9-19. doi:10.1016/j.bbi.2006.08.009.
115. Pekny, M., and Nilsson, M. (2005). Astrocyte activation and reactive gliosis. Glia 50, 427-434. doi:10.1002/glia.20207.
116. Persson, M., Brantefjord, M., Hansson, E., and Rönnbäck, L. (2005). Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-a. Glia 51, 111-120. doi:10.1002/glia.20191.
117. Persson, M., Pekna, M., Hansson, E., and Rönnbäck, L. (2009). The complement-derived anaphylatoxin C5a increases microglial GLT-1 expression and glutamate uptake in a TNF-a- independent manner. European Journal of Neuroscience 29, 267274. doi:10.1111/j.1460- 9568.2008.06575.x.
118. Powell, N., Bailey, M., Mays, J., Stiner-Jones, L., Hanke, M., Padgett, D., and Sheridan, J. (2009). Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain, behavior, and immunity 23, 225-31. doi:10.1016/j.bbi.2008.09.010.
119. Qiu, J., Xu, J., Zheng, Y., Wei, Y., Zhu, X., Lo, E., Moskowitz, M., and Sims, J. (2010). Highmobility group box 1 promotes metalloproteinase-9 upregulation through Toll-like receptor 4 after cerebral ischemia. Stroke; a journal of cerebral circulation 41, 2077-82. doi:10.1161/strokeaha.110.590463.
120. Quak, J., Doornbos, B., Roest, A., Duivis, H., Vogelzangs, N., Nolen, W., Penninx, B., Kema, I., and Jonge, P. (2014). Does tryptophan degradation along the kynurenine pathway mediate the association between pro-inflammatory immune activity and depressive symptoms? Psychoneuroendocrinology 45, 202210. doi:10.1016/j.psyneuen.2014.03.013.
121. Quan, N., Avitsur, R., Stark, J., He, L., Lai, W., Dhabhar, F., and Sheridan, J. (2003). Molecular mechanisms of glucocorticoid resistance in splenocytes of socially stressed male mice. Journal of Neuroimmunology 137, 51-58. doi:10.1016/S0165-5728(03)00042-0.
122. Ransohoff, R., and Brown, M. (2012). Innate immunity in the central nervous system. The Journal of clinical investigation 122, 1164-71. doi:10.1172/jci58644.
123. Ratman, D., Berghe, W., Dejager, L., Libert, C., Tavernier, J., Beck, I., and Bosscher, K. (2013). How glucocorticoid receptors modulate the activity of other transcription factors: a scope beyond tethering. Molecular and cellular endocrinology 380, 41-54. doi:10.1016/j.mce.2012.12.014.
124. Ricketson, D., Hostick, U., Fang, L., Yamamoto, K., and Darimont, B. (2007). A Conformational Switch in the Ligand-binding Domain Regulates the Dependence of the Glucocorticoid Receptor on Hsp90. Journal of Molecular Biology 368, 729741. doi:10.1016/j.jmb.2007.02.057.
125. Rubin, R., Miller, T., Rhodes, M., and Czambel, R. (2006). Adrenal cortical responses to low- and high-dose ACTH1-24 administration in major depressives vs. matched controls. Psychiatry Research 143, 4350. doi:10.1016/j.psychres.2005.10.003.
126. Rybakowski, J., Remlinger-Molenda, A., Czech-Kucharska, A., Wojcicka, M., Michalak, M., and Losy, J. (2013). Increased serum matrix metalloproteinase-9 (MMP-9) levels in young patients during bipolar depression. Journal of affective disorders 146, 286-9. doi:10.1016/j.jad.2012.07.019.
127. Sapolsky, R., Romero, L., and Munck, A. (2000). How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions1. Endocrine Reviews 21, 5589. doi:10.1210/edrv.21.1.0389.
128. Schipke, C., Heuser, I., and Peters, O. (2011). Antidepressants act on glial cells: SSRIs and serotonin elicit astrocyte calcium signaling in the mouse prefrontal cortex. Journal of psychiatric research 45, 242-8. doi:10.1016/j.jpsychires.2010.06.005.
129. Schlaak, J., Trippler, M., Hoyo-Becerra, C., Erim, Y., Kis, B., Wang, B., Scherbaum, N., and Gerken, G. (2012). Selective hyper-responsiveness of the interferon system in major depressive disorders and depression induced by interferon therapy. PloS one 7, e38668. doi:10.1371/journal.pone.0038668.
130. Schwartz, M., Kipnis, J., Rivest, S., and Prat, A. (2013). How do immune cells support and shape the brain in health, disease, and aging? The Journal of neuroscience: the official journal of the Society for Neuroscience 33, 17587-96. doi:10.1523/jneurosci.3241-13.2013.
131. Schweingruber, N., Fischer, H., Fischer, L., Brandt, J., Karabinskaya, A., Labi, V., Villunger, A., Kretzschmar, B., Huppke, P., Simons, M., et al. (2014). Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses. Acta Neuropathologica 127, 713729. doi:10.1007/s00401-014-1248-4.
132. Sharma, G., and Vijayaraghavan, S. (2001). Nicotinic cholinergic signaling in hippocampal astrocytes involves calcium-induced calcium release from intracellular stores. Proceedings of the National Academy of Sciences 98, 4148-4153. doi:10.1073/pnas.071540198.
133. Shieh, C.-H., Heinrich, A., Serchov, T., Calker, D., and Biber, K. (2014). P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-a in cultured mouse microglia. Glia 62, 592607. doi:10.1002/glia.22628.
134. Silverman, M. N., Mukhopadhyay, P., Belyavskaya, E., Tonelli, L. H., Revenis, B. D., Doran, J. H., Ballard, B. E., Tam, J., Pacher, P., and Sternberg, E. M. (2013). Glucocorticoid receptor dimerization is required for proper recovery of LPS-induced inflammation, sickness behavior and metabolism in mice. Molecular psychiatry 18, 1006-17. doi:10.1038/mp.2012.131.
135. Silverman, M. N., and Sternberg, E. M. (2012). Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Annals of the New York Academy of Sciences 1261, 55-63. doi:10.1111/j.1749-6632.2012.06633.x.
136. Simic, I., Mitic, M., Djordjevic, J., Radojcic, M., and Adzic, M. (2012). Chronic stress decreases availability of heat shock proteins to glucocorticoid receptor in response to novel acute stress in Wistar rat hypothalamus. Cellular and molecular neurobiology 32, 625-32. doi:10.1007/s10571-012-9811-9.
137. Smith-Thomas, L., Fok-Seang, J., Stevens, J., Du, J., Muir, E., Faissner, A., Geller, H., Rogers, J., and Fawcett, J. (1994). An inhibitor of neurite outgrowth produced by astrocytes. Journal of cell science 107 ( Pt 6), 1687-95.
138. Solomon, G. F., Allansmith, M., McCellan, B., and Amkraut, A. (1969). Immunoglobulins in psychiatric patients. Archives of general psychiatry 20, 272-7.
139. Sominsky, L., Fuller, E. A., Bondarenko, E., Ong, L. K., Averell, L., Nalivaiko, E., Dunkley, P. R., Dickson, P. W., and Hodgson, D. M. (2013). Functional programming of the autonomic nervous system by early life immune exposure: implications for anxiety. PloS one 8, e57700. doi:10.1371/journal.pone.0057700.
140. Starkman, M. N., Schteingart, D. E., and Schork, M. A. (1981). Depressed mood and other psychiatric manifestations of Cushing's syndrome: relationship to hormone levels. Psychosomatic medicine 43, 3-18.
141. Stevens, C., Aravind, S., Das, S., and Davis, R. (2013). Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. British journal of pharmacology 168, 1421-9. doi:10.1111/bph.12028.
142. Sun, D., and Jakobs, T. (2012). Structural remodeling of astrocytes in the injured CNS. The Neuroscientist: a review journal bringing neurobiology, neurology and psychiatry 18, 567- 88. doi:10.1177/1073858411423441.
143. Sundholm-Peters, N., Yang, H., Goings, G., Walker, A., and Szele, F. (2005). Subventricular Zone Neuroblasts Emigrate Toward Cortical Lesions. Journal of Neuropathology and Experimental Neurology 64, 10891100. doi:10.1097/01.jnen.0000190066.13312.8f.
144. Tazi, A., Dantzer, R., Crestani, F., and Moal, M. (1988). Interleukin-1 induces conditioned taste aversion in rats: a possible explanation for its pituitary-adrenal stimulating activity. Brain Research 473, 369371. doi:10.1016/0006-8993(88)90868-2.
145. Temburni, M., and Jacob, M. (2001). New functions for glia in the brain. Proceedings of the National Academy of Sciences 98, 3631-3632. doi:10.1073/pnas.081073198.
146. Theoharides, T., Spanos, C., Pang, X., Alferes, L., Ligris, K., Letourneau, R., Rozniecki, J., Webster, E., and Chrousos, G. (1995). Stress-induced intracranial mast cell degranulation: a corticotropin-releasing hormone-mediated effect. Endocrinology 136, 57455750. doi:10.1210/endo.136.12.7588332.
147. Tilleux, S., and Hermans, E. (2008). Down-regulation of astrocytic GLAST by microglia-related inflammation is abrogated in dibutyryl cAMP-differentiated cultures. Journal of neurochemistry 105, 2224-36. doi:10.1111/j.1471-4159.2008.05305.x.
148. Triantafilou, M., and Triantafilou, K. (2004). Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharide. Biochemical Society transactions 32, 636-9. doi:10.1042/BST0320636.
149. Vakharia, K., and Hinson, J. (2004). Lipopolysaccharide Directly Stimulates Cortisol Secretion by Human Adrenal Cells by a Cyclooxygenase-Dependent Mechanism. Endocrinology 146, 1398-1402. doi:10.1210/en.2004-0882.
150. Viviani, B., Boraso, M., Marchetti, N., and Marinovich, M. (2014). Perspectives on neuroinflammation and excitotoxicity: A neurotoxic conspiracy? NeuroToxicology. doi:10.1016/j.neuro.2014.03.004.
151. Vogel, D., Heijnen, P., Breur, M., Vries, H., Tool, A., Amor, S., and Dijkstra, C. (2014). Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. Journal of neuroinflammation 11, 23. doi:10.1186/1742-2094-11-23.
152. Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012). Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380, 2163-96. doi:10.1016/S0140-6736(12)61729-2.
153. Warner-Schmidt, J., Vanover, K., Chen, E., Marshall, J., and Greengard, P. (2011). Antidepressant effects of selective serotonin reuptake inhibitors (SSRIs) are attenuated by antiinflammatory drugs in mice and humans. Proceedings of the National Academy of Sciences of the United States of America 108, 9262-7. doi:10.1073/pnas.1104836108.
154. Watters, T., Kenny, E., and O'Neill, L. (2007). Structure, function and regulation of the Toll/IL- 1 receptor adaptor proteins. Immunology and Cell Biology 85, 411-419. doi:10.1038/sj.icb.7100095.
155. Weber, M., Frank, M., Sobesky, J., Watkins, L., and Maier, S. (2013). Blocking toll-like receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge. Brain, behavior, and immunity 32, 112-21. doi:10.1016/j.bbi.2013.03.004.
156. Whiteford, H., Degenhardt, L., Rehm, J., Baxter, A., Ferrari, A., Erskine, H., Charlson, F., Norman, R., Flaxman, A., Johns, N., et al. (2013). Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382, 1575-86. doi:10.1016/s0140-6736(13)61611-6.
157. Williams, D., Calderon, T., Lopez, L., Carvallo-Torres, L., Gaskill, P., Eugenin, E., Morgello, S., and Berman, J. (2013). Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis. PloS one 8, e69270. doi:10.1371/journal.pone.0069270.
158. Wohleb, E. S., McKim, D. B., Shea, D. T., Powell, N. D., Tarr, A. J., Sheridan, J. F., and Godbout, J. P. (2014). Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biological psychiatry 75, 970-81. doi:10.1016/j.biopsych.2013.11.029.
159. Wohleb, E. S., Powell, N. D., Godbout, J. P., and Sheridan, J. F. (2013). Stress-induced recruitment of bone marrow-derived monocytes to the brain promotes anxiety-like behavior. The Journal of neuroscience: the official journal of the Society for Neuroscience 33, 13820-33. doi:10.1523/JNEUROSCI.1671-13.2013.
160. Wong, D., Prameya, R., and Dorovinizis, K. (2007). Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. Journal of Neuroimmunology 184, 136148. doi:10.1016/j.jneuroim.2006.12.003.
161. Wu, T.-C., Chen, H.-T., Chang, H.-Y., Yang, C.-Y., Hsiao, M.-C., Cheng, M.-L., and Chen, J.-C. (2013). Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 38, 871-83. doi:10.1016/j.psyneuen.2012.09.011.
162. Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J., and Tong, L. (2000). Structural basis for signal transduction by the Toll/interleukin-1 receptordomains. Nature 408, 111-115. doi:10.1038/35040600.
163. Yamaguchi, N., Ogawa, S., and Okada, S. (2010). Cyclooxygenase and nitric oxide synthase in the presympathetic neurons in the paraventricular hypothalamic nucleus are involved in restraint stress-induced sympathetic activation in rats. Neuroscience 170, 773-81. doi:10.1016/j.neuroscience.2010.07.051.
164. Yuan, Y.-M., and He, C. (2013). The glial scar in spinal cord injury and repair. Neuroscience bulletin 29, 421-35. doi:10.1007/s12264-013-1358-3.
165. Zacharowski, K., Zacharowski, P., Koch, A., Baban, A., Tran, N., Berkels, R., Papewalis, C., Schulze-Osthoff, K., Knuefermann, P., Zähringer, U., et al. (2006). Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proceedings of the National Academy of Sciences 103, 6392-6397. doi:10.1073/pnas.0601527103.
166. Zhang, F., Zhou, H., Wilson, B., Shi, J.-S., Hong, J.-S., and Gao, H.-M. (2012). Fluoxetine protects neurons against microglial activation-mediated neurotoxicity. Parkinsonism & Related Disorders 18, S213S217. doi:10.1016/S1353-8020(11)70066-9.
167. Zhao, M., Zhou, A., Xu, L., and Zhang, X. (2014). The role of TLR4-mediated PTEN/PI3K/AKT/NF-?B signaling pathway in neuroinflammation in hippocampal neurons. Neuroscience 269, 93101. doi:10.1016/j.neuroscience.2014.03.039.
168. Zhong, H.-J., Wang, H.-Y., Yang, C., Zhou, J.-Y., and Jiang, J.-X. (2013). Low Concentrations of Corticosterone Exert Stimulatory Effects on Macrophage Function in a Manner Dependent on Glucocorticoid Receptors. International Journal of Endocrinology 2013, 19. doi:10.1155/2013/405127.